PARP-2 mediates cardiomyocyte aging and damage induced by doxorubicin through SIRT1 Inhibition
Chaoming Huang, Xuan Zhang, Shulin Wang, Ao Shen, Tianfen Xu, Yanhong Hou, Shuhan Gao, Yongwan Xie, Yi Zeng, Jiayu Chen, Runxiang Lin, Yu Zhang, Chunpeng Wan, Yi Cai
Topics & Concepts
Poly ADP ribose polymeraseDoxorubicinCardiotoxicityCardiomyopathyCancer researchHeart failureAnthracyclinePARP inhibitorBiologyPharmacologyCell biologyPolymeraseChemistryMedicineEnzymeInternal medicineChemotherapyCancerBiochemistryBreast cancerChemotherapy-induced cardiotoxicity and mitigationPARP inhibition in cancer therapyElectron Spin Resonance Studies